A pharma medical affairs veteran explains why real-world evidence’s biggest constraint isn’t data volume; it’s having enough people to interpret what AI finds.
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
3 Steps To Improve Site Acceptance Of ePRO In Medical Device Trials
Discover how with the proper understanding of a site’s barriers, early engagement, and prioritizing effective training, site acceptance of ePRO can be improved.
-
Essity Uses eConsent To Optimize Enrollment
See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.
-
Key To A Faster, More Flexible Clinical Trial Process
Discover how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.
-
Reduce The Need To Perform A 12-Lead ECG In Resource Limited Settings
Remote cardiac monitoring technology is enabling the pharmaceutical industry to shift towards innovative, efficient, and patient-friendly clinical trials.
-
Configurability And Customization: Key Features In An eTMF Solution
Discover how a configurable and customizable eTMF can lend itself to better information control during a clinical trial while boosting security and regulatory compliance efforts.
-
FDA Guidance Has Implications For EDC And EHR eSource Capabilities
Gain insight from an eSource study observing digitally received data as far back as 2007 to just before initial guidance was released by the U.S. FDA in 2013.
-
Oncology Trials: Accuracy And Alleviating The Patient Screening Burden
Flatiron Health has unveiled an innovative service designed to enhance patient screening for clinical trials by integrating structured EHR data with machine learning and human analysis.
-
The Real Reason Sites Haven't Digitized
Reducing site burden doesn’t require major change. Streamlining one workflow can boost efficiency, support compliance, and free staff to focus on patients.
-
How EDCs Are Changing The Game In Clinical Research
Explore all things EDC in this article: what it is, how researchers can use it in clinical trials, its numerous benefits, and examples of how these translate into the real world.
-
Email: The Gold Standard For Clinical Trials
Although non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives